Get the Stockscreener App
1.17
1.74%
0.02
After Hours:
1.16
-0.01
-0.85%
60 Degrees Pharmaceuticals Inc stock is traded at $1.17, with a volume of 34,954.
It is up +1.74% in the last 24 hours and up +3.54% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
See More
Previous Close:
$1.15
Open:
$1.16
24h Volume:
34,954
Relative Volume:
0.46
Market Cap:
$4.11M
Revenue:
$1.31M
Net Income/Loss:
$-7.56M
P/E Ratio:
-0.1137
EPS:
-10.2926
Net Cash Flow:
$-8.25M
1W Performance:
+22.38%
1M Performance:
+3.54%
6M Performance:
-24.52%
1Y Performance:
-78.96%
1-Day Range:
$1.12
$1.17
1-Week Range:
$0.94
$1.20
52-Week Range:
$0.84
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.17 | 4.11M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus - Investing.com
SXTP: Label expansion for ARAKODA into babesiosis advances, with pivotal milestones expected by 2028 - TradingView
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus By Investing.com - Investing.com India
SXTP: Label expansion for ARAKODA into babesiosis aims for regulatory milestones and launch by 2028 - TradingView
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – BOATS:SXTPW - TradingView
60 Degrees Pharmaceuticals Flags Cash Runway Only Into Early October - minichart.com.sg
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases - TipRanks
60 Degrees Pharmaceuticals updates investor presentation outlining tafenoquine babesiosis sNDA path, Q2 results and July financing - TradingView
60 Degrees Pharma flags going-concern risk - Stock Titan
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
A pharmaceutical company will post a public presentation Sept. 11. Its management will meet investors in New York. - Stock Titan
60 DEGREES PHARMACEUTICALS, INC. SEC Filing (Aug 26, 2026) - Stock Titan
Degrees (SXTP) Q1 2026 Earnings: The EPS Result Is Below Expectation in the Latest Reading; Stock Move: The Stock Finishes Near Unchanged in Latest TradingRevenue Warning Signal - careplusvn.com
Degrees (SXTP) Snapshot: Closes with Little Net Change at $1.13 at the Close; Next Test: Price Remains Between $1.07 Support and $1.19 Resistance in the Current UpdateSentiment Divergence - vinanet.vn
Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo
SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet
SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher by 1.27% as Shares Test Key Resistance at $1.26Bollinger Band - vinanet.vn
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Stock News Today - TradingKey
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - tradingview.com
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss of $1.28 Per Share Sends Stock Down 16.11%Surprise Factor Analysis - careplusvn.com
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedShare Dilution Risk - careplusvn.com
60 Degrees Pharmaceuticals (SXTP) Edges Lower as Stock Tests Key Support LevelsAscending Triangle - careplusvn.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):